Top Gainers Today
Visit highsandlows.substack.com to see more

Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Post media
Nathan Worden's avatar
Was looking for a reason for the 42% gain in Alnylam $ALNY. Looks like they had a heart disease drug meet a goal in it's late-stage trial. More here:

Author

Related